Research focusing on lncRNAs, such as prostate cancer antigen 3 (PCA3) (13) and metastasis associated lung adenocarcinoma transcript 1 (MALAT1) (14), may improve current screening techniques to identify patients at risk for PCa. The gene discussed is PCA3; the disease is posterior cortical atrophy.